Drug · DIN 02411199
CENTRISA 21
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 3, 2017.
- Drug Identification Number (DIN)
- 02411199
- Company (DIN owner)
- Patriot A Division Of Janssen IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Norgestimate and estrogen G03AB11
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORGESTIMATE | 0.180 MG | |
| ETHINYL ESTRADIOL | 0.035 MG | |
| NORGESTIMATE | 0.215 MG | |
| ETHINYL ESTRADIOL | 0.035 MG | |
| NORGESTIMATE | 0.250 MG | |
| ETHINYL ESTRADIOL | 0.035 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 6, 2013: NOC 14711New Drug Submission (NDS)